CD274 and neoplasm: In peripheral tissues, the effector phase of the adaptive immune response against tumor cells is partly negatively regulated through the binding of the programmed cell death protein 1 (PD-1) expressed on activated T-cells with the ligands PD-L1 or PD-L2 expressed on tumor cells.